Management and Challenges in Peripheral Arterial Disease
This special issue belongs to the section "Cardiovascular Clinical Research".
Special Issue Information
Dear Colleagues,
Atherosclerotic peripheral artery disease (PAD) is a major manifestation of cardiovascular disease. More than 200 million individuals worldwide suffer from PAD and such patients have amongst the highest morbidity and mortality rates. In addition, the associated costs are even higher than after stroke, as shown in recent population-based studies.
Recent advances, including antiplatelet and lipid-lowering therapies, along with innovations in endovascular treatment, such as thrombectomy, atherectomy, and lithotripsy, have created great opportunities to improve treatment algorithms in PAD and, possibly, patient related outcomes. Nonetheless, there is a clear need for novel evidence-based treatment strategies to effectively treat PAD patients and reduce the burden of the disease. These encompass pharmacologic as well as endovascular and surgical strategies. PAD treatment has been the focus of major global efforts to improve diagnostic, therapeutic, and preventive strategies.
The aim of our Special Issue is, thus, to collect original articles and reviews investigating pathophysiologic, diagnostic, and therapeutic aspects related to the management of PAD.
Prof. Dr. Christos Rammos
Prof. Dr. Grigorios Korosoglou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peripheral vascular interventions
- endovascular/hybrid/surgical therapy
- peripheral perfusion
- primary prevention
- secondary prevention
- peripheral artery disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
J. Cardiovasc. Dev. Dis. - ISSN 2308-3425